Protective antibodies after vaccination with human diploid cell rabies vaccine.
1983
C Wasi, and
P Chaiprasithikul, and
P Thongcharoen, and
V Rungpitarungsi, and
C Tharachan, and
S Likanontsakul
UI
MeSH Term
Description
Entries
D008297
Male
Males
D011819
Rabies Vaccines
Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis.
Rabies Human Diploid Cell Vaccine,Rabies Vaccine,Vaccine, Rabies,Vaccines, Rabies
D011820
Rabies virus
The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates.
Rabies viruses
D005260
Female
Females
D006801
Humans
Members of the species Homo sapiens.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.
Adults
D000914
Antibodies, Viral
Immunoglobulins produced in response to VIRAL ANTIGENS.
Viral Antibodies
Related Publications
C Wasi, and
P Chaiprasithikul, and
P Thongcharoen, and
V Rungpitarungsi, and
C Tharachan, and
S Likanontsakul